Want to see AMWL full AI Analyst Report?
AMWL Stock Chart & Stats
$10.81
$0.25(2.31%)
At close: 4:00 PM EDT
$10.81
$0.25(2.31%)
Day’s Range― - ―
52-Week Range$3.71 - $13.45
Previous CloseN/A
Volume57.88K
Average Volume (3M)94.74K
Market Cap
$181.12M
Enterprise Value-$75.99
Total Cash (Recent Filing)$179.21M
Total Debt (Recent Filing)$3.96M
Price to Earnings (P/E)―
Beta1.97
Next Earnings
Aug 04, 2026EPS Estimate
-0.86Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.42
Shares Outstanding15,061,188
10 Day Avg. Volume80,702
30 Day Avg. Volume94,738
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.33
Price to Sales (P/S)0.32
P/FCF Ratio-1.19
Enterprise Value/Market Cap>-0.01
Enterprise Value/Revenue>-0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$8.90Price Target Upside-17.67% Downside
Rating ConsensusHold
Number of Analyst Covering7
EPS Forecast (FY)-3.19
Revenue Forecast (FY)$202.33M
Bulls Say, Bears Say
Bulls Say
Low Leverage / Cash RunwayVery low debt and a sizable cash balance give Amwell flexibility to fund execution, invest in product and endure near-term revenue pressure without immediate refinancing. This conservatism reduces solvency risk and supports a multi-quarter path to break-even while management executes cost plans.
Improving Profitability TrajectoryMaterial year-over-year improvement in adjusted EBITDA, large opex reductions (~31% YoY) and sharply lower quarterly cash burn demonstrate durable cost structure changes. Sustained expense discipline and narrowing EBITDA loss underpin management's stated route to positive operating cash flow later in the fiscal year.
Stronger Recurring Mix & Enterprise ValidationA majority-recurring revenue mix, a multi-year renewal from a large payer and growth in higher-value AMG visits increase revenue predictability and validate product-market fit with enterprise customers. These structural shifts support more stable future cash flows if churn stabilizes.
Bears Say
Top-line DeclineSustained revenue contraction undermines scalable economics: lower volumes reduce gross profit and limit the ability to leverage fixed costs. Even with margin improvements, ongoing top-line declines create a persistent headwind to achieving durable profitability and cash-flow stability over the next several quarters.
Persistent Negative Cash FlowConsistent negative operating and free cash flow necessitates reliance on existing liquidity or capital markets until break-even is achieved. This structural cash burn elevates dilution and execution risk if revenue recovery lags the company's timeline to positive operating cash flow.
Customer Concentration & Churn RiskDependence on a few large customers makes revenue volatile and renewals binary; recent churn materially reduced subscription revenue. High concentration magnifies downside from contract losses and weakens negotiating leverage, posing a structural risk to durable recurring revenue growth.
American Well News
AMWL FAQ
What was American Well’s price range in the past 12 months?
American Well lowest stock price was $3.71 and its highest was $13.45 in the past 12 months.
What is American Well’s market cap?
American Well’s market cap is $181.12M.
When is American Well’s upcoming earnings report date?
American Well’s upcoming earnings report date is Aug 04, 2026 which is in 2 days.
How were American Well’s earnings last quarter?
American Well released its earnings results on May 05, 2026. The company reported -$0.66 earnings per share for the quarter, beating the consensus estimate of -$1.174 by $0.514.
Is American Well overvalued?
According to Wall Street analysts American Well’s price is currently Overvalued.
Does American Well pay dividends?
American Well does not currently pay dividends.
What is American Well’s EPS estimate?
American Well’s EPS estimate is -0.86.
How many shares outstanding does American Well have?
American Well has 15,061,188 shares outstanding.
What happened to American Well’s price movement after its last earnings report?
American Well reported an EPS of -$0.66 in its last earnings report, beating expectations of -$1.174. Following the earnings report the stock price went up 12.421%.
Which hedge fund is a major shareholder of American Well?
Currently, no hedge funds are holding shares in AMWL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
American Well Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$8.90 (-17.67% Downside)
$8.90 (-17.67% Downside)
Blogger Sentiment
Neutral
AMWL Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 3.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $323.2K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
11.54%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-22.29%
Trailing 12-Months
Company Description
American Well
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
AMWL Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed balanced but constructive progress: clear operational and cost improvements drove meaningful profitability trajectory (adjusted EBITDA and operating loss improvement), a stronger recurring revenue mix, sizable pipeline expansion, and government/customer validations (Elevance renewal, DHA deployment). Offsetting these positives were continued top-line headwinds—total revenue down ~18%, subscription revenue down ~23%, and total platform visits down ~19%—and the company remains unprofitable on a GAAP basis for 2026. Management's guidance (narrowed adjusted EBITDA loss range), strong cash position, reduced cash burn, and confidence in reaching cash flow breakeven in Q4 2026 tilt the overall tone optimistic despite near-term revenue and usage declines.View all AMWL earnings summariesAMWL Revenue Breakdown
46.12% Visits
43.37% Platform subscription
10.50% Other
AMWL Stock 12 Month Forecast
Average Price Target
$8.90
▼(-17.67% Downside)
Technical Analysis
Ownership Overview
10.65% Insiders
10.74% Mutual Funds
0.14% Other Institutional Investors
73.64% Public Companies and
Individual Investors